News

Published on 20 Feb 2024 on Zacks via Yahoo Finance

Repare Therapeutics Inc. (RPTX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release


Article preview image

Wall Street expects a year-over-year increase in earnings on lower revenues when Repare Therapeutics Inc. (RPTX) reports results for the quarter ended December 2023. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

NASDAQ.RPTX price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
United States shares mixed at close of trade; Dow Jones Industrial Average down...

United States shares mixed at close of trade; Dow Jones Industrial Average down 0.20%

Investing.com 13 Dec 2024

Why Is Repare Therapeutics Stock Trading Lower On Friday?

On Thursday, Repare Therapeutics Inc (NASDAQ:RPTX) revealed data from its MYTHIC Phase 1 gynecolo...

Benzinga · via Yahoo Finance 13 Dec 2024

Repare Therapeutics Inc. (RPTX): A Promising Penny Stock in Canada’s Evolving...

We recently compiled a list of the 10 Best Canadian Penny Stocks to Buy Now. In this article, we ...

Insider Monkey · via Yahoo Finance 22 Aug 2024

Repare Therapeutics Inc.'s (NASDAQ:RPTX) market cap dropped US$21m last week; Private equity firms...

Key Insights Significant control over Repare Therapeutics by private equity firms implies that th...

Simply Wall St. via Yahoo Finance 21 Apr 2024

Repare Therapeutics Inc (RPTX) Reports Financial Outcomes for Q4 and Full Year 2023

Revenue: Reported a decrease to $13.0 million in Q4 and $51.1 million for the full year, compared...

GuruFocus.com via Yahoo Finance 28 Feb 2024

Repare Therapeutics Inc. (RPTX) May Report Negative Earnings: Know the Trend Ahead of Q4 Release

Wall Street expects a year-over-year increase in earnings on lower revenues when Repare Therapeut...

Zacks via Yahoo Finance 20 Feb 2024

Repare Therapeutics Inc. (RPTX) Soars 8.8%: Is Further Upside Left in the Stock?

Repare Therapeutics Inc. (RPTX) shares ended the last trading session 8.8% higher at $8.41. The j...

Zacks via Yahoo Finance 13 Feb 2024

Repare Therapeutics (RPTX) Rises 34% in a Week: Here's Why

Repare Therapeutics Inc. RPTX is using its genome-wide, CRISPR-enabled SNIPRx platform to discove...

Zacks via Yahoo Finance 22 Nov 2023

Repare Therapeutics Inc. (NASDAQ:RPTX) most popular amongst private equity firms who own 33% of the...

Key Insights The considerable ownership by private equity firms in Repare Therapeutics indicates ...

Simply Wall St. via Yahoo Finance 12 Nov 2023

Repare Therapeutics Inc (RPTX) Reports Q3 2023 Financial Results Amid Pipeline Progress

Repare Therapeutics Inc (NASDAQ:RPTX) presented promising initial data from the Phase 1 MYTHIC cl...

GuruFocus.com via Yahoo Finance 9 Nov 2023